Wockhardt (WOCKPHARMA) | Stock Overview & Key Data
Wockhardt Performance Comparison
Stock Range
Today's Range
Low: ₹1,448.00
High: ₹1,548.80
on August 8, 2025
52 Week Range
Low: ₹882.00
High: ₹1,868.80
on August 8, 2024
on June 12, 2025
All-Time High: ₹2,168.80 on March 11, 2013
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR246.8B
EPS
-3.09
P/E Ratio (TTM)
-487.48
Forward P/E
N/A
P/B Ratio
5.58
PEG Ratio
5.38
Div. Yield
N/A
ROE
-1.37%
Beta
1.276
Debt to Equity
43.40
Financial Highlights
Profitability
Gross Margin
65.01%
Operating Margin
6.40%
Profit Margin
-1.55%
Returns and Earnings
Return on Assets (TTM)
1.61%
Return on Equity (TTM)
-1.37%
EBITDA
INR4.6B
Net Income (TTM)
INR-470.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR186.79
Quarterly Revenue Growth (YoY)
4.60%
Quarterly Earnings Growth (YoY)
7.53%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Wockhardt WOCKPHARMA | 246.84B Large-cap | -8.70% | -11.20% | 19.19% | -3.11% | 1.13% | 53.90% | 522.23% | 356.57% |
| Sun Pharmaceutical SUNPHARMA | 3.84T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
| Torrent TORNTPHARM | 1.21T Large-cap | -2.85% | 7.55% | 12.16% | 11.91% | 4.52% | 7.03% | 132.03% | 25.86% |
| Cipla CIPLA | 1.20T Large-cap | -1.18% | -0.22% | -0.12% | 1.79% | 0.38% | 3.58% | 45.16% | 93.18% |
| Mankind Pharma MANKIND | 1.05T Large-cap | -3.87% | 1.46% | 1.13% | -1.40% | -14.37% | 15.49% | 76.92% | 76.92% |
Ownership & Short Interest
Insider Ownership
51.02%
Institutional Ownership
12.77%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
704K
Average 90-Day Volume
762K
Wockhardt Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Wockhardt would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is WOCKPHARMA's 52-week high and low?
- In the last 52 weeks, Wockhardt reached a high of ₹1,868.80 (on June 12, 2025) and a low of ₹882.00 (on August 8, 2024).
- What is the market cap and P/E ratio for WOCKPHARMA?
- Curious about Wockhardt's size and valuation? Its market capitalization stands at 246.84B. When it comes to valuation, the P/E ratio (trailing twelve months) is -487.48, and the forward P/E (looking ahead) is N/A.
- Does WOCKPHARMA pay dividends? If so, what's the yield?
- As for dividends, Wockhardt isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Wockhardt's main competitors or similar companies to consider before investing?
When looking at Wockhardt, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.84T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% Torrent
TORNTPHARM1.21T Healthcare Drug Manufacturers - Specialty & Generic 7.03% 132.03% Cipla
CIPLA1.20T Healthcare Drug Manufacturers - Specialty & Generic 3.58% 45.16% Mankind Pharma
MANKIND1.05T Healthcare Drug Manufacturers - Specialty & Generic 15.49% 76.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Wockhardt Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Wockhardt's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.37%, the Debt to Equity ratio from the most recent quarter is 43.40, and its Gross Profit Margin stands at 65.01%.
- What is the recent revenue and earnings growth for WOCKPHARMA?
- Looking at Wockhardt's growth, its revenue over the trailing twelve months (TTM) was INR30B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.60%, and quarterly earnings saw a YoY growth of 7.53%.
- How much of WOCKPHARMA stock is held by insiders and institutions?
- Wondering who owns Wockhardt stock? Company insiders (like executives and directors) hold about 51.02% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.